首页 > 最新文献

Journal of Stroke & Cerebrovascular Diseases最新文献

英文 中文
Admission red blood cell distribution width as a prognostic biomarker of stroke-associated pneumonia and mortality in acute ischemic stroke patients treated with thrombolysis
IF 2 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-01-31 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108254
Sarawut Krongsut , Nat Na-Ek , Nop Khongthon

Background

Red blood cell distribution width (RDW) is an inflammatory marker potentially linked to stroke-associated pneumonia (SAP). This study assessed RDW's role in predicting SAP, mortality, and poor outcomes in acute ischemic stroke (AIS) patients treated with thrombolysis.

Methods

A retrospective analysis (2015–2022) of AIS patients treated with thrombolysis examined admission RDW levels. Outcomes included SAP, in-hospital (IHM) and 3-month mortality, and poor functional outcomes. Associations were analyzed using multivariable logistic regression, with predictive performance assessed via area under a receiver operating characteristic curve (AuROC), net reclassification index (NRI), and integrated discrimination improvement (IDI) metrics.

Results

Of 345 patients, 70 (20.3 %) developed SAP. A 1-SD increase in RDW was associated with SAP (adjusted odds ratio [aOR]: 1.73; 95 % CI: 1.27–2.35), IHM (aOR: 2.14; 95 % CI: 1.43–3.21), and 3-month mortality (aOR: 1.74; 95 % CI: 1.19–2.56). The association was stronger in non-diabetics and those under 65. Although RDW did not improve the AuROC for SAP or mortality predictions, it significantly improved the NRI and IDI (p < 0.05).

Conclusions

RDW is independently associated with increased risk of SAP, IHM, and 3-month mortality in AIS patients treated with thrombolysis, suggesting its potential as a prognostic marker.
{"title":"Admission red blood cell distribution width as a prognostic biomarker of stroke-associated pneumonia and mortality in acute ischemic stroke patients treated with thrombolysis","authors":"Sarawut Krongsut ,&nbsp;Nat Na-Ek ,&nbsp;Nop Khongthon","doi":"10.1016/j.jstrokecerebrovasdis.2025.108254","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108254","url":null,"abstract":"<div><h3>Background</h3><div>Red blood cell distribution width (RDW) is an inflammatory marker potentially linked to stroke-associated pneumonia (SAP). This study assessed RDW's role in predicting SAP, mortality, and poor outcomes in acute ischemic stroke (AIS) patients treated with thrombolysis.</div></div><div><h3>Methods</h3><div>A retrospective analysis (2015–2022) of AIS patients treated with thrombolysis examined admission RDW levels. Outcomes included SAP, in-hospital (IHM) and 3-month mortality, and poor functional outcomes. Associations were analyzed using multivariable logistic regression, with predictive performance assessed via area under a receiver operating characteristic curve (AuROC), net reclassification index (NRI), and integrated discrimination improvement (IDI) metrics.</div></div><div><h3>Results</h3><div>Of 345 patients, 70 (20.3 %) developed SAP. A 1-SD increase in RDW was associated with SAP (adjusted odds ratio [aOR]: 1.73; 95 % CI: 1.27–2.35), IHM (aOR: 2.14; 95 % CI: 1.43–3.21), and 3-month mortality (aOR: 1.74; 95 % CI: 1.19–2.56). The association was stronger in non-diabetics and those under 65. Although RDW did not improve the AuROC for SAP or mortality predictions, it significantly improved the NRI and IDI (<em>p</em> &lt; 0.05).</div></div><div><h3>Conclusions</h3><div>RDW is independently associated with increased risk of SAP, IHM, and 3-month mortality in AIS patients treated with thrombolysis, suggesting its potential as a prognostic marker.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 4","pages":"Article 108254"},"PeriodicalIF":2.0,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The health-related quality of life among stroke survivors with post-COVID conditions living in the United States
IF 2 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-01-30 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108246
Seyyed Sina Hejazian , Ajith Vemuri , Alireza Vafaei Sadr , Shima Shahjouei , Sasan Bahrami , Vida Abedi , Ramin Zand

Background and aim

It is widely recognized that a considerable number of COVID-19 survivors continue to experience post-COVID conditions (PCCs). Given that stroke survivors face a heightened risk of PCCs compared to the general population, our objective was to assess the impact of PCCs on the health-related quality of life (HRQL) among stroke survivors in the United States.

Method

We used the Behavioral Risk Factor Surveillance System data 2022. Respondents with a history of COVID-19 infection and stroke were selected and classified based on whether they experienced PCCs. Finally, the HRQL-related items, including self-reported general health (SRGH), the number of days with compromised mental and physical health, and the daily efficiency, were compared between the two groups.

Results

Overall, 3988 respondents (42.8 % aged above 64 years old, 45.8 % men) were enrolled. Compared to stroke survivors without PCCs, those with PCCs had significantly worse SRGH and a higher number of days with compromised mental and physical health. However, although multivariate regression analysis supported the adverse impact of PCCs on the SRGH of stroke survivors, the results were not statistically significant (aOR = 1.32,CI95 %:[0.98-1.78],p = 0.070). Fatigue and dyspnea emerged as the most significantly associated symptoms with impaired SRGH. Additionally, lower education and annual household income level, smoking, lack of physical activity, and comorbidities including diabetes, heart, and pulmonary disease were associated with a higher prevalence of unfavorable SRGH among stroke survivors with PCCs.

Conclusion

Our study highlights that PCCs might be associated with worse SRGH. Lower education, income, and physical activity, smoking, and comorbidities were associated with a higher rate of unfavorable SRGH among stroke survivors with PCCs.
{"title":"The health-related quality of life among stroke survivors with post-COVID conditions living in the United States","authors":"Seyyed Sina Hejazian ,&nbsp;Ajith Vemuri ,&nbsp;Alireza Vafaei Sadr ,&nbsp;Shima Shahjouei ,&nbsp;Sasan Bahrami ,&nbsp;Vida Abedi ,&nbsp;Ramin Zand","doi":"10.1016/j.jstrokecerebrovasdis.2025.108246","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108246","url":null,"abstract":"<div><h3>Background and aim</h3><div>It is widely recognized that a considerable number of COVID-19 survivors continue to experience post-COVID conditions (PCCs). Given that stroke survivors face a heightened risk of PCCs compared to the general population, our objective was to assess the impact of PCCs on the health-related quality of life (HRQL) among stroke survivors in the United States.</div></div><div><h3>Method</h3><div>We used the Behavioral Risk Factor Surveillance System data 2022. Respondents with a history of COVID-19 infection and stroke were selected and classified based on whether they experienced PCCs. Finally, the HRQL-related items, including self-reported general health (SRGH), the number of days with compromised mental and physical health, and the daily efficiency, were compared between the two groups.</div></div><div><h3>Results</h3><div>Overall, 3988 respondents (42.8 % aged above 64 years old, 45.8 % men) were enrolled. Compared to stroke survivors without PCCs, those with PCCs had significantly worse SRGH and a higher number of days with compromised mental and physical health. However, although multivariate regression analysis supported the adverse impact of PCCs on the SRGH of stroke survivors, the results were not statistically significant (aOR = 1.32,CI95 %:[0.98-1.78],p = 0.070). Fatigue and dyspnea emerged as the most significantly associated symptoms with impaired SRGH. Additionally, lower education and annual household income level, smoking, lack of physical activity, and comorbidities including diabetes, heart, and pulmonary disease were associated with a higher prevalence of unfavorable SRGH among stroke survivors with PCCs.</div></div><div><h3>Conclusion</h3><div>Our study highlights that PCCs might be associated with worse SRGH. Lower education, income, and physical activity, smoking, and comorbidities were associated with a higher rate of unfavorable SRGH among stroke survivors with PCCs.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 4","pages":"Article 108246"},"PeriodicalIF":2.0,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143076311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "Door-to-Needle Time Trends After Transition to Tenecteplase: A Multicenter Texas Stroke Registry" [Journal of Stroke and Cerebrovascular Diseases 33 (2024) 107774].
IF 2 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-01-29 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108250
Nathaniel Rodriguez, Sidarrth Prasad, DaiWai M Olson, Sujani Bandela, Gretchel Gealogo Brown, Yoon Kwon, Mehari Gebreyohanns, Erica M Jones, Nneka L Ifejika, Suzanne Stone, Jane A Anderson, Sean I Savitz, Salvador Cruz-Flores, Steven J Warach, Mark P Goldberg, Lee A Birnbaum
{"title":"Corrigendum to \"Door-to-Needle Time Trends After Transition to Tenecteplase: A Multicenter Texas Stroke Registry\" [Journal of Stroke and Cerebrovascular Diseases 33 (2024) 107774].","authors":"Nathaniel Rodriguez, Sidarrth Prasad, DaiWai M Olson, Sujani Bandela, Gretchel Gealogo Brown, Yoon Kwon, Mehari Gebreyohanns, Erica M Jones, Nneka L Ifejika, Suzanne Stone, Jane A Anderson, Sean I Savitz, Salvador Cruz-Flores, Steven J Warach, Mark P Goldberg, Lee A Birnbaum","doi":"10.1016/j.jstrokecerebrovasdis.2025.108250","DOIUrl":"https://doi.org/10.1016/j.jstrokecerebrovasdis.2025.108250","url":null,"abstract":"","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":" ","pages":"108250"},"PeriodicalIF":2.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143069732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thrombolysis in lacunar stroke: Comparison of early neurological improvement and 90-day functional outcome with cardioembolic stroke without large-vessel occlusion
IF 2 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-01-29 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108245
Ádám Annus MD, PhD , Nikolett Halmai MD , Evelin Fehér PhD , Gábor Tárkányi MD , László Szapáry MD, PhD, DSc , István Szegedi MD, PhD , László Csiba MD, PhD, DSc , László Vécsei MD, PhD, DSc , László Sztriha MD, PhD, FRCP , Péter Klivényi MD, PhD, DSc

Introduction

Thrombolysis (IVT) is effective in the treatment of lacunar stroke (LAC). However, most studies compared the outcome of LAC to a heterogenous control group. We aimed to compare early neurological improvement (ENI) and late functional outcomes following thrombolysis for LAC with a homogenous control group of cardioembolic stroke (CE) without large-vessel occlusion (LVO).

Patients and methods

Patient data were obtained from the national multicentre STAY ALIVE Acute Stroke Registry. At each centre, a team of vascular neurologists determined the TOAST classification. ENI was defined as a minimum 4-point decrease in the NIHSS score between admission and discharge, or a complete resolution of symptoms. For late functional outcome, we analysed the dichotomised 90-day mRS scores (good outcome was mRS≤2).

Results

142 LAC and 156 CE patients were analysed. Following IVT, the percentage of ENI did not differ significantly (LAC 41.1% vs CE 49.7%, p=0.154), and multivariable analysis did not identify any clinical parameters that would predict ENI after IVT in either group. LAC patients had unfavourable, albeit non-significant, odds of having good 90-day functional outcomes compared to CE patients (aOR 0.483, 95% CI 0.201-1.161, p=104).

Conclusions

We report the first analysis of short- and long-term outcomes of IVT in LAC, using a homogenous control group of CE patients without LVO. The prevalence of ENI and 90-day functional outcomes were similar. However, LAC patients had unfavourable odds of achieving good functional outcomes compared to the control group. Therefore, we emphasise that LAC should not be considered a minor stroke subtype.
{"title":"Thrombolysis in lacunar stroke: Comparison of early neurological improvement and 90-day functional outcome with cardioembolic stroke without large-vessel occlusion","authors":"Ádám Annus MD, PhD ,&nbsp;Nikolett Halmai MD ,&nbsp;Evelin Fehér PhD ,&nbsp;Gábor Tárkányi MD ,&nbsp;László Szapáry MD, PhD, DSc ,&nbsp;István Szegedi MD, PhD ,&nbsp;László Csiba MD, PhD, DSc ,&nbsp;László Vécsei MD, PhD, DSc ,&nbsp;László Sztriha MD, PhD, FRCP ,&nbsp;Péter Klivényi MD, PhD, DSc","doi":"10.1016/j.jstrokecerebrovasdis.2025.108245","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108245","url":null,"abstract":"<div><h3>Introduction</h3><div>Thrombolysis (IVT) is effective in the treatment of lacunar stroke (LAC). However, most studies compared the outcome of LAC to a heterogenous control group. We aimed to compare early neurological improvement (ENI) and late functional outcomes following thrombolysis for LAC with a homogenous control group of cardioembolic stroke (CE) without large-vessel occlusion (LVO).</div></div><div><h3>Patients and methods</h3><div>Patient data were obtained from the national multicentre STAY ALIVE Acute Stroke Registry. At each centre, a team of vascular neurologists determined the TOAST classification. ENI was defined as a minimum 4-point decrease in the NIHSS score between admission and discharge, or a complete resolution of symptoms. For late functional outcome, we analysed the dichotomised 90-day mRS scores (good outcome was mRS≤2).</div></div><div><h3>Results</h3><div>142 LAC and 156 CE patients were analysed. Following IVT, the percentage of ENI did not differ significantly (LAC 41.1% vs CE 49.7%, p=0.154), and multivariable analysis did not identify any clinical parameters that would predict ENI after IVT in either group. LAC patients had unfavourable, albeit non-significant, odds of having good 90-day functional outcomes compared to CE patients (aOR 0.483, 95% CI 0.201-1.161, p=104).</div></div><div><h3>Conclusions</h3><div>We report the first analysis of short- and long-term outcomes of IVT in LAC, using a homogenous control group of CE patients without LVO. The prevalence of ENI and 90-day functional outcomes were similar. However, LAC patients had unfavourable odds of achieving good functional outcomes compared to the control group. Therefore, we emphasise that LAC should not be considered a minor stroke subtype.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 4","pages":"Article 108245"},"PeriodicalIF":2.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143076314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between heart rate variability traits and stroke: A Mendelian randomization study
IF 2 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-01-27 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108251
Wei Liu MM , Yexin Xin MM , Mengyu Sun MM , Chenlong Liu MM , Xiangrong Yin MM , Xiaofei Xu PhD , Yilei Xiao PhD
<div><h3>Background</h3><div>Previous observational studies have suggested a potential association between heart rate variability (HRV) and cerebrovascular disease. However, a causal relationship between the two has not yet been established.</div></div><div><h3>Aims</h3><div>The objective of this study was to determine the causal relationship between heart rate variability (HRV) and stroke through a two-sample Mendelian randomization analysis.</div></div><div><h3>Methods</h3><div>Three genetic predictive traits of heart rate variability standard deviation of the normal-to-normal interbeat intervals (SDNN), the root mean square of the successive differences of interbeat intervals (RMSSD), and the peak-valley respiratory sinus arrhythmia or high-frequency power (pvRSA/HF) were collected from publicly available genome-wide association studies (IEU Open GWAS). Additionally, stroke (STROKE) and its sub-types: ischemic stroke (IS), cardioembolic stroke (CES), small vessel stroke (SVS), large artery stroke (LAS), lacunar stroke (LS), and intracerebral hemorrhage (ICH)were also from this database. Two-sample Mendelian randomization and various sensitivity analyses were employed to explore the causal relationship between HRV and stroke and its sub-types. Inverse-variance weighted (IVW) was the primary method via which Mendelian randomization (MR) was conducted, and for the causal estimates determined by IVW, a series of sensitivity analyses were performed to assess the reliability of the results. (i) Four additional MR methods that complement IVW were utilized; (ii) Cochran's Q-test was employed for assessing heterogeneity; (iii) the MR-Egger's intercept test and MR-PRESSO global test were applied to assess the level of multivariate validity, and (iv) the "leave-one-out" method was utilized to assess stability.</div></div><div><h3>Results</h3><div>Two of the genetically predictive traits of HRV (standard deviation of the normal-to-normal interbeat intervals [SDNN]) and (the peak-valley respiratory sinus arrhythmia or high-frequency power [pvRSA/HF]) were associated with IS (OR 0.63,95 %CI 0.42-0.95, <em>P =</em> 0.03), (OR 0.84, 95 %CI: 0.72-1.00; <em>P =</em> 0.04), and LAS (OR 135.93, 95 %CI: 7.19-2569.22; <em>P =</em> 0.05), (OR 1.42, 95 %CI: 1.02-1.98; <em>P =</em> 0.04) were significantly correlated in addition to (pvRSA/HF) and LS (OR 0.84, 95 %CI: 0.72-1.00; <em>P =</em> 0.04) were also causally associated. Neither was causally associated with other sub-types of stroke or hemorrhagic stroke. Another genetically predictive trait of HRV (the root mean square of the successive differences of interbeat intervals [RMSSD]) was not found to be significantly associated with stroke, its subtypes, or Intracerebral hemorrhage.</div></div><div><h3>Conclusion</h3><div>This study provides genetic evidence supporting the causal effects of HRV (SDNN) on ischemic stroke (IS) and large artery stroke (LAS), as well as (pvRSA/HF) on ischemic stroke (IS), large artery
{"title":"Relationship between heart rate variability traits and stroke: A Mendelian randomization study","authors":"Wei Liu MM ,&nbsp;Yexin Xin MM ,&nbsp;Mengyu Sun MM ,&nbsp;Chenlong Liu MM ,&nbsp;Xiangrong Yin MM ,&nbsp;Xiaofei Xu PhD ,&nbsp;Yilei Xiao PhD","doi":"10.1016/j.jstrokecerebrovasdis.2025.108251","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108251","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Previous observational studies have suggested a potential association between heart rate variability (HRV) and cerebrovascular disease. However, a causal relationship between the two has not yet been established.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Aims&lt;/h3&gt;&lt;div&gt;The objective of this study was to determine the causal relationship between heart rate variability (HRV) and stroke through a two-sample Mendelian randomization analysis.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;Three genetic predictive traits of heart rate variability standard deviation of the normal-to-normal interbeat intervals (SDNN), the root mean square of the successive differences of interbeat intervals (RMSSD), and the peak-valley respiratory sinus arrhythmia or high-frequency power (pvRSA/HF) were collected from publicly available genome-wide association studies (IEU Open GWAS). Additionally, stroke (STROKE) and its sub-types: ischemic stroke (IS), cardioembolic stroke (CES), small vessel stroke (SVS), large artery stroke (LAS), lacunar stroke (LS), and intracerebral hemorrhage (ICH)were also from this database. Two-sample Mendelian randomization and various sensitivity analyses were employed to explore the causal relationship between HRV and stroke and its sub-types. Inverse-variance weighted (IVW) was the primary method via which Mendelian randomization (MR) was conducted, and for the causal estimates determined by IVW, a series of sensitivity analyses were performed to assess the reliability of the results. (i) Four additional MR methods that complement IVW were utilized; (ii) Cochran's Q-test was employed for assessing heterogeneity; (iii) the MR-Egger's intercept test and MR-PRESSO global test were applied to assess the level of multivariate validity, and (iv) the \"leave-one-out\" method was utilized to assess stability.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Two of the genetically predictive traits of HRV (standard deviation of the normal-to-normal interbeat intervals [SDNN]) and (the peak-valley respiratory sinus arrhythmia or high-frequency power [pvRSA/HF]) were associated with IS (OR 0.63,95 %CI 0.42-0.95, &lt;em&gt;P =&lt;/em&gt; 0.03), (OR 0.84, 95 %CI: 0.72-1.00; &lt;em&gt;P =&lt;/em&gt; 0.04), and LAS (OR 135.93, 95 %CI: 7.19-2569.22; &lt;em&gt;P =&lt;/em&gt; 0.05), (OR 1.42, 95 %CI: 1.02-1.98; &lt;em&gt;P =&lt;/em&gt; 0.04) were significantly correlated in addition to (pvRSA/HF) and LS (OR 0.84, 95 %CI: 0.72-1.00; &lt;em&gt;P =&lt;/em&gt; 0.04) were also causally associated. Neither was causally associated with other sub-types of stroke or hemorrhagic stroke. Another genetically predictive trait of HRV (the root mean square of the successive differences of interbeat intervals [RMSSD]) was not found to be significantly associated with stroke, its subtypes, or Intracerebral hemorrhage.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;This study provides genetic evidence supporting the causal effects of HRV (SDNN) on ischemic stroke (IS) and large artery stroke (LAS), as well as (pvRSA/HF) on ischemic stroke (IS), large artery ","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 4","pages":"Article 108251"},"PeriodicalIF":2.0,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143048600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the genetic causal inference between plasma lipidome and hemorrhagic stroke
IF 2 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-01-26 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108252
Zhao Yu MM , Yingjie Shen MD , Haopeng Zhang MD , Wei Zhang MM , Xi Zhang MM , Yaolou Wang MM , Chenyi Nie MS , Jiaxin Zhou MS , Aili Gao PhD , Hongsheng Liang MD, PhD

Objectives

Recent research indicates that the plasma lipidome composition may undergo alterations following hemorrhagic stroke. Nevertheless, the causal inference between plasma lipidome and hemorrhagic stroke remains elusive.

Materials and methods

Exposure data were achieved from a recent Genome-wide Association Study (GWAS) study of 179 lipid species involving 7174 individuals, while the outcome data were obtained from the FinnGen consortium (R10), including intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), and non-traumatic intracranial hemorrhage (nITH). Two-sample bidirectional Mendelian randomization (MR) analyses were used to assess the causal inference between lipidome and hemorrhagic stroke, and inverse variance weighted served as the main method. Genetic correlations between lipidome and hemorrhagic stroke were assessed using linkage disequilibrium score regression (LDSC).

Results

After the false discovery rate (FDR) correction, Phosphatidylcholine (O-18:2_20:4) was identified as a substantial risk factor for ICH (OR,1.199; 95 % CI, 1.073–1.341; PFDR = 0.073). Alternatively, Phosphatidylinositol (16:0_18:1) was a relevant protective factor (OR, 0.773; 95 % CI, 0.666–0.896; PFDR = 0.069). Furthermore, the Sterol ester (27:1/20:3) (OR, 1.138; 95 % CI, 1.024–1.264; PFDR = 0.086) was identified as the prominent risk factor for SAH. Finally, Sterol ester (27:1/20:4) (OR, 1.073; 95 % CI, 1.026–1.121; PFDR = 0.030) and Phosphatidylinositol (16:0_18:1) levels (OR, 0.794; 95 % CI, 0.709–0.889; PFDR = 0.007) was identified as risk and protective factors for nITH, respectively.

Conclusions

The causal relationship between plasma lipidome and hemorrhagic stroke is evident. Studying the plasma lipidome offers promising preventive strategies and potential therapeutic approaches for hemorrhagic stroke.
{"title":"Exploring the genetic causal inference between plasma lipidome and hemorrhagic stroke","authors":"Zhao Yu MM ,&nbsp;Yingjie Shen MD ,&nbsp;Haopeng Zhang MD ,&nbsp;Wei Zhang MM ,&nbsp;Xi Zhang MM ,&nbsp;Yaolou Wang MM ,&nbsp;Chenyi Nie MS ,&nbsp;Jiaxin Zhou MS ,&nbsp;Aili Gao PhD ,&nbsp;Hongsheng Liang MD, PhD","doi":"10.1016/j.jstrokecerebrovasdis.2025.108252","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108252","url":null,"abstract":"<div><h3>Objectives</h3><div>Recent research indicates that the plasma lipidome composition may undergo alterations following hemorrhagic stroke. Nevertheless, the causal inference between plasma lipidome and hemorrhagic stroke remains elusive.</div></div><div><h3>Materials and methods</h3><div>Exposure data were achieved from a recent Genome-wide Association Study (GWAS) study of 179 lipid species involving 7174 individuals, while the outcome data were obtained from the FinnGen consortium (R10), including intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), and non-traumatic intracranial hemorrhage (nITH). Two-sample bidirectional Mendelian randomization (MR) analyses were used to assess the causal inference between lipidome and hemorrhagic stroke, and inverse variance weighted served as the main method. Genetic correlations between lipidome and hemorrhagic stroke were assessed using linkage disequilibrium score regression (LDSC).</div></div><div><h3>Results</h3><div>After the false discovery rate (FDR) correction, Phosphatidylcholine (O-18:2_20:4) was identified as a substantial risk factor for ICH (OR,1.199; 95 % CI, 1.073–1.341; <em>P</em><sub>FDR</sub> = 0.073). Alternatively, Phosphatidylinositol (16:0_18:1) was a relevant protective factor (OR, 0.773; 95 % CI, 0.666–0.896; <em>P</em><sub>FDR</sub> = 0.069). Furthermore, the Sterol ester (27:1/20:3) (OR, 1.138; 95 % CI, 1.024–1.264; <em>P</em><sub>FDR</sub> = 0.086) was identified as the prominent risk factor for SAH. Finally, Sterol ester (27:1/20:4) (OR, 1.073; 95 % CI, 1.026–1.121; <em>P</em><sub>FDR</sub> = 0.030) and Phosphatidylinositol (16:0_18:1) levels (OR, 0.794; 95 % CI, 0.709–0.889; <em>P</em><sub>FDR</sub> = 0.007) was identified as risk and protective factors for nITH, respectively.</div></div><div><h3>Conclusions</h3><div>The causal relationship between plasma lipidome and hemorrhagic stroke is evident. Studying the plasma lipidome offers promising preventive strategies and potential therapeutic approaches for hemorrhagic stroke.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 4","pages":"Article 108252"},"PeriodicalIF":2.0,"publicationDate":"2025-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143061403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-procedural Plasma D-dimer Level May Predict Futile Recanalization in Stroke Patients with Endovascular Treatment.
IF 2 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-01-23 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108248
Min Zhao, Zhengze Dai, Rui Liu, Xinfeng Liu, Gelin Xu

Objective: High D-dimer levels may increase the likelihood of unfavorable clinical outcomes in patients with acute ischemic stroke. However, the impacts of serum D-dimer levels on outcomes of reperfusion treatment in patients with acute ischemic stroke have not been evaluated. This study aims to assess a possible relationship between serum D-dimer and functional outcomes in stroke patients with endovascular treatment (EVT).

Methods: Patients with acute ischemic stroke who underwent successful EVT were enrolled. Plasma D-dimer was measured before and within 6 hours after endovascular procedures. Futile recanalization was defined as a modified Rankin Scale score of 3-6 at 90 days of stroke onset. Multivariable logistic regression analyses were performed to determine the relationships between D-dimer and futile recanalization.

Results: Of the 161 enrolled patients, 78 (48.4%) were classified as futile recanalization. After adjusting for potential confounders, high post-procedural D-dimer level was associated with futile recanalization (odds ratio, 1.25; 95% CI, 1.05-1.51; P =0.016). In patients with futile recanalization, change in serum D-dimer levels increased significantly after EVT (P <0.001). Furthermore, change in D-dimer level after EVT was associated with futile recanalization (odds ratio, 1.33; 95% CI, 1.11-1.65; P =0.005) independently.

Conclusions: High post-procedural plasma D-dimer levels and a significant increase in D-dimer after EVT may predict futile recanalization in patients with acute ischemic stroke.

{"title":"Post-procedural Plasma D-dimer Level May Predict Futile Recanalization in Stroke Patients with Endovascular Treatment.","authors":"Min Zhao, Zhengze Dai, Rui Liu, Xinfeng Liu, Gelin Xu","doi":"10.1016/j.jstrokecerebrovasdis.2025.108248","DOIUrl":"https://doi.org/10.1016/j.jstrokecerebrovasdis.2025.108248","url":null,"abstract":"<p><strong>Objective: </strong>High D-dimer levels may increase the likelihood of unfavorable clinical outcomes in patients with acute ischemic stroke. However, the impacts of serum D-dimer levels on outcomes of reperfusion treatment in patients with acute ischemic stroke have not been evaluated. This study aims to assess a possible relationship between serum D-dimer and functional outcomes in stroke patients with endovascular treatment (EVT).</p><p><strong>Methods: </strong>Patients with acute ischemic stroke who underwent successful EVT were enrolled. Plasma D-dimer was measured before and within 6 hours after endovascular procedures. Futile recanalization was defined as a modified Rankin Scale score of 3-6 at 90 days of stroke onset. Multivariable logistic regression analyses were performed to determine the relationships between D-dimer and futile recanalization.</p><p><strong>Results: </strong>Of the 161 enrolled patients, 78 (48.4%) were classified as futile recanalization. After adjusting for potential confounders, high post-procedural D-dimer level was associated with futile recanalization (odds ratio, 1.25; 95% CI, 1.05-1.51; P =0.016). In patients with futile recanalization, change in serum D-dimer levels increased significantly after EVT (P <0.001). Furthermore, change in D-dimer level after EVT was associated with futile recanalization (odds ratio, 1.33; 95% CI, 1.11-1.65; P =0.005) independently.</p><p><strong>Conclusions: </strong>High post-procedural plasma D-dimer levels and a significant increase in D-dimer after EVT may predict futile recanalization in patients with acute ischemic stroke.</p>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":" ","pages":"108248"},"PeriodicalIF":2.0,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143042811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Blockage of p38MAPK in astrocytes alleviates brain damage in a mouse model of embolic stroke through the CX43/AQP4 axis” [J Stroke Cerebrovasc Dis. 2024 Dec;33(12):108085/Article Number: YJSCD_JSCVD-D-24-00861] “星形胶质细胞p38MAPK阻断通过CX43/AQP4轴减轻栓塞性脑卒中小鼠模型脑损伤”的勘误[J]卒中脑血管病,2024年12月;33(12):108085/文章编号:YJSCD_JSCVD-D-24-00861。
IF 2 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-01-19 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108229
Weiping Chen , Zhiping Wu , Min Yin , Yangbo Zhang , Yiren Qin , Xu Liu , Jianglong Tu
{"title":"Corrigendum to “Blockage of p38MAPK in astrocytes alleviates brain damage in a mouse model of embolic stroke through the CX43/AQP4 axis” [J Stroke Cerebrovasc Dis. 2024 Dec;33(12):108085/Article Number: YJSCD_JSCVD-D-24-00861]","authors":"Weiping Chen ,&nbsp;Zhiping Wu ,&nbsp;Min Yin ,&nbsp;Yangbo Zhang ,&nbsp;Yiren Qin ,&nbsp;Xu Liu ,&nbsp;Jianglong Tu","doi":"10.1016/j.jstrokecerebrovasdis.2025.108229","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108229","url":null,"abstract":"","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 3","pages":"Article 108229"},"PeriodicalIF":2.0,"publicationDate":"2025-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential of low apolipoprotein A-I as a surrogate marker of vulnerable carotid artery plaques 低载脂蛋白a - i作为易损颈动脉斑块的替代标志物的潜力。
IF 2 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-01-19 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108231
Saya Tsuchigauchi MD , Toshinori Matsushige MD , Yukishige Hashimoto MD , Masahiro Hosogai MD , Hiroki Takahashi MD , Shohei Kobayashi MD , Takeo Shishido MD , Naoyuki Hara MD , Kenta Kaneyoshi MD , Shota Uchida MD , Ryuga Maki MD , Hiroshi Yamashita MD

Objective

Recent studies suggested that the medical control of atherogenic lipoproteins is not sufficient for stroke prevention. A low apolipoprotein A-I (apoA-I) level may play a crucial role in the anti-atherogenic effects of high-density lipoprotein (HDL-C) and may also be associated with symptomatic vulnerable plaques in carotid artery stenosis. Therefore, the present study investigated the relationship between apoA-I levels and the status of carotid artery stenosis.

Methods

Ninety-one patients with carotid artery stenosis were examined. The status of carotid artery plaques was divided into symptomatic (n = 47) and asymptomatic (n = 44). We examined patient profiles, including comorbidities, and laboratory lipid data, and plaque features visualized by ultrasonography, MRI, and digital subtraction angiography. The relationships between plaque instability and risk factors for carotid artery stenosis were investigated.

Results

No significant differences were observed in the profiles of symptomatic and asymptomatic patients. Regarding plaque features, ulceration, low echo luminance, and a high signal intensity in plaques on T1-weighted images correlated with symptomatic plaques. ApoA-I, total cholesterol, and non-HDL-C levels were significantly lower in symptomatic patients than in asymptomatic patients. A multivariate logistic regression analysis identified low ApoA-I levels, ulceration, and low echo luminance as predictive factors for symptomatic carotid artery stenosis. Diagnostic accuracy for predicting symptomatic carotid stenosis was 0.84 when the following four factors were combined: ulceration, low echo luminance, a high signal intensity on T1-weighted images, and the level of apoA-I.

Conclusions

A low apoA-I level was associated with symptomatic carotid artery stenosis. Therefore, ApoA-I levels have potential as a surrogate marker to detect unstable carotid artery plaques.
目的:最近的研究表明,药物控制致动脉粥样硬化脂蛋白不足以预防脑卒中。低载脂蛋白A- i (apoA-I)水平可能在高密度脂蛋白(HDL-C)的抗动脉粥样硬化作用中起关键作用,也可能与颈动脉狭窄的症状性易损斑块有关。因此,本研究探讨apoA-I水平与颈动脉狭窄状态的关系。方法:对91例颈动脉狭窄患者进行检查。将颈动脉斑块分为有症状(n= 47)和无症状(n= 44)。我们检查了患者资料,包括合并症、实验室脂质数据,以及超声、MRI和数字减影血管造影显示的斑块特征。探讨斑块不稳定性与颈动脉狭窄危险因素的关系。结果:有症状和无症状患者的特征无显著差异。关于斑块特征,斑块在t1加权图像上溃疡、低回声亮度和高信号强度与症状斑块相关。有症状患者的ApoA-I、总胆固醇和非hdl - c水平明显低于无症状患者。多因素logistic回归分析发现低ApoA-I水平、溃疡和低回声亮度是症状性颈动脉狭窄的预测因素。溃疡、低回声亮度、t1加权像高信号强度、apoA-I水平4个因素综合考虑,对症状性颈动脉狭窄的诊断准确率为0.84。结论:低apoa - 1水平与症状性颈动脉狭窄相关。因此,ApoA-I水平有可能作为检测不稳定颈动脉斑块的替代标志物。
{"title":"Potential of low apolipoprotein A-I as a surrogate marker of vulnerable carotid artery plaques","authors":"Saya Tsuchigauchi MD ,&nbsp;Toshinori Matsushige MD ,&nbsp;Yukishige Hashimoto MD ,&nbsp;Masahiro Hosogai MD ,&nbsp;Hiroki Takahashi MD ,&nbsp;Shohei Kobayashi MD ,&nbsp;Takeo Shishido MD ,&nbsp;Naoyuki Hara MD ,&nbsp;Kenta Kaneyoshi MD ,&nbsp;Shota Uchida MD ,&nbsp;Ryuga Maki MD ,&nbsp;Hiroshi Yamashita MD","doi":"10.1016/j.jstrokecerebrovasdis.2025.108231","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108231","url":null,"abstract":"<div><h3>Objective</h3><div>Recent studies suggested that the medical control of atherogenic lipoproteins is not sufficient for stroke prevention. A low apolipoprotein A-I (apoA-I) level may play a crucial role in the anti-atherogenic effects of high-density lipoprotein (HDL-C) and may also be associated with symptomatic vulnerable plaques in carotid artery stenosis. Therefore, the present study investigated the relationship between apoA-I levels and the status of carotid artery stenosis.</div></div><div><h3>Methods</h3><div>Ninety-one patients with carotid artery stenosis were examined. The status of carotid artery plaques was divided into symptomatic (<em>n</em> = 47) and asymptomatic (<em>n</em> = 44). We examined patient profiles, including comorbidities, and laboratory lipid data, and plaque features visualized by ultrasonography, MRI, and digital subtraction angiography. The relationships between plaque instability and risk factors for carotid artery stenosis were investigated.</div></div><div><h3>Results</h3><div>No significant differences were observed in the profiles of symptomatic and asymptomatic patients. Regarding plaque features, ulceration, low echo luminance, and a high signal intensity in plaques on T1-weighted images correlated with symptomatic plaques. ApoA-I, total cholesterol, and non-HDL-C levels were significantly lower in symptomatic patients than in asymptomatic patients. A multivariate logistic regression analysis identified low ApoA-I levels, ulceration, and low echo luminance as predictive factors for symptomatic carotid artery stenosis. Diagnostic accuracy for predicting symptomatic carotid stenosis was 0.84 when the following four factors were combined: ulceration, low echo luminance, a high signal intensity on T1-weighted images, and the level of apoA-I.</div></div><div><h3>Conclusions</h3><div>A low apoA-I level was associated with symptomatic carotid artery stenosis. Therefore, ApoA-I levels have potential as a surrogate marker to detect unstable carotid artery plaques.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 4","pages":"Article 108231"},"PeriodicalIF":2.0,"publicationDate":"2025-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between body roundness index and stroke results from the 1999-2018 NHANES 1999-2018年NHANES的身体圆度指数与中风结果之间的关系。
IF 2 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-01-17 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108243
Jiale Gan , Xinyi Yang , Jianan Wu , Peiyi Mo , Yongxing Deng , Yan Liu , Yang Wu , Peian Liu , Lianhong Ji , Hui Jiang , Yunfei Han , Zhaoyao Chen , Wenlei Li , Yuan Zhu , Minghua Wu

Importance

Obesity, especially visceral obesity, is a controllable risk factor associated with the incidence of stroke. The body roundness index (BRI) bridges the gap between traditional anthropometric methods of assessing fat distribution to predict the percentage of body fat and visceral adipose tissue, which can be used to decipher its population-based characteristics and potential association with stroke.

Objective

The negative impact of accumulated visceral obesity on cerebrovascular health has been widely documented. However, the association between BRI and stroke has never been reported before. The purpose of this study was to elucidate the connection between BRI and the general incidence of stroke in the US population.

Design, Setting, and Participants

This cohort study extracted cross-sectional data from 39,454 U.S. adults (aged ≥20 years) from documents related to the National Health and Nutrition Examination Survey (NHANES) from 1999 through 2018.

Methods

We evaluated the relationship between BRI and stroke using weighted logistic regression analysis, and we looked at any possible nonlinear relationships using restricted cubic spline (RCS) regression. Additionally, subgroup analysis and interaction tests were carried out.

Results

The study involved 39,454 participants, of whom 1,427 (3.6 %) had a stroke. Fully adjusted logistic regression models showed that BRI was positively associated with stroke, with a 5.7 % increase in stroke incidence per unit increase in BRI (OR = 1.057, 95 % CI = 1.009,1.108, P = 0.020). RCS analysis revealed a nonlinear association, suggesting an elevated risk of stroke before the inflection point of 8.489. This positive correlation was consistent across settings, according to subgroup analyses and interaction tests (P > 0.05 for all interactions).

Conclusions and relevance

There is a nonlinear positive correlation between BRI and stroke, according to this national cohort study. These results support the use of the BRI as a screening tool for assessing stroke risk; yet, because cross-sectional studies have inherent limitations, more thorough research is required until the BRI has been consistently validated in additional independent cohorts.
重要性:肥胖,尤其是内脏肥胖,是与卒中发病率相关的可控危险因素。身体圆度指数(BRI)弥补了评估脂肪分布的传统人体测量方法之间的差距,以预测身体脂肪和内脏脂肪组织的百分比,可用于解读其基于人群的特征及其与中风的潜在关联。目的:积累性内脏性肥胖对脑血管健康的负面影响已被广泛报道。然而,BRI与中风之间的关联从未被报道过。本研究的目的是阐明在美国人群中BRI与卒中一般发病率之间的联系。设计、环境和参与者:本队列研究从1999年至2018年的国家健康与营养检查调查(NHANES)相关文件中提取了39,454名美国成年人(年龄≥20岁)的横断面数据。方法:我们使用加权逻辑回归分析评估BRI与卒中之间的关系,并使用限制三次样条(RCS)回归研究任何可能的非线性关系。此外,还进行了亚组分析和交互作用试验。结果:该研究涉及39,454名参与者,其中1,427名(3.6%)患有中风。完全调整后的logistic回归模型显示BRI与卒中呈正相关,BRI每增加一个单位卒中发生率增加5.7% (OR = 1.057, 95% CI = 1.009,1.108, P = 0.020)。RCS分析显示出一种非线性关联,提示在8.489拐点之前卒中风险升高。根据亚组分析和相互作用试验,这种正相关性在不同设置下是一致的(所有相互作用的P < 0.05)。结论和相关性:根据这项国家队列研究,BRI和卒中之间存在非线性正相关。这些结果支持使用BRI作为评估卒中风险的筛查工具;然而,由于横断面研究具有固有的局限性,在BRI在其他独立队列中得到一致验证之前,需要进行更彻底的研究。
{"title":"Association between body roundness index and stroke results from the 1999-2018 NHANES","authors":"Jiale Gan ,&nbsp;Xinyi Yang ,&nbsp;Jianan Wu ,&nbsp;Peiyi Mo ,&nbsp;Yongxing Deng ,&nbsp;Yan Liu ,&nbsp;Yang Wu ,&nbsp;Peian Liu ,&nbsp;Lianhong Ji ,&nbsp;Hui Jiang ,&nbsp;Yunfei Han ,&nbsp;Zhaoyao Chen ,&nbsp;Wenlei Li ,&nbsp;Yuan Zhu ,&nbsp;Minghua Wu","doi":"10.1016/j.jstrokecerebrovasdis.2025.108243","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108243","url":null,"abstract":"<div><h3>Importance</h3><div>Obesity, especially visceral obesity, is a controllable risk factor associated with the incidence of stroke. The body roundness index (BRI) bridges the gap between traditional anthropometric methods of assessing fat distribution to predict the percentage of body fat and visceral adipose tissue, which can be used to decipher its population-based characteristics and potential association with stroke.</div></div><div><h3>Objective</h3><div>The negative impact of accumulated visceral obesity on cerebrovascular health has been widely documented. However, the association between BRI and stroke has never been reported before. The purpose of this study was to elucidate the connection between BRI and the general incidence of stroke in the US population.</div></div><div><h3>Design, Setting, and Participants</h3><div>This cohort study extracted cross-sectional data from 39,454 U.S. adults (aged ≥20 years) from documents related to the National Health and Nutrition Examination Survey (NHANES) from 1999 through 2018.</div></div><div><h3>Methods</h3><div>We evaluated the relationship between BRI and stroke using weighted logistic regression analysis, and we looked at any possible nonlinear relationships using restricted cubic spline (RCS) regression. Additionally, subgroup analysis and interaction tests were carried out.</div></div><div><h3>Results</h3><div>The study involved 39,454 participants, of whom 1,427 (3.6 %) had a stroke. Fully adjusted logistic regression models showed that BRI was positively associated with stroke, with a 5.7 % increase in stroke incidence per unit increase in BRI (OR = 1.057, 95 % CI = 1.009,1.108, <em>P</em> = 0.020). RCS analysis revealed a nonlinear association, suggesting an elevated risk of stroke before the inflection point of 8.489. This positive correlation was consistent across settings, according to subgroup analyses and interaction tests (<em>P</em> &gt; 0.05 for all interactions).</div></div><div><h3>Conclusions and relevance</h3><div>There is a nonlinear positive correlation between BRI and stroke, according to this national cohort study. These results support the use of the BRI as a screening tool for assessing stroke risk; yet, because cross-sectional studies have inherent limitations, more thorough research is required until the BRI has been consistently validated in additional independent cohorts.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 3","pages":"Article 108243"},"PeriodicalIF":2.0,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Stroke & Cerebrovascular Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1